Location History:
- München, DE (2008 - 2020)
- Munich, DE (2007 - 2024)
Company Filing History:
5 out of 155 
4 out of 63 
1 out of 4 
Years Active: 2007-2025
Title: Innovations in Cancer Treatment: The Contributions of Inventor Michael Dahm
Introduction
Michael Dahm, an accomplished inventor based in Munich, Germany, has made significant strides in the field of cancer therapy. With a remarkable portfolio consisting of eight patents, Dahm has focused on utilizing advanced virology techniques to develop innovative treatments aimed at combating various forms of cancer. His pioneering work reflects a commitment to improving patient outcomes and advancing medical science.
Latest Patents
Among his latest patents is a groundbreaking invention that combines cancer therapy with an oncolytic virus and a checkpoint inhibitor. This pharmaceutical composition demonstrates the potential for enhanced efficacy in cancer treatment by leveraging the synergetic properties of these two agents. Additionally, Dahm holds a patent for a parvovirus formulation designed specifically for treating tumors. This formulation includes parvovirus H1 or related rodent parvoviruses and is intended for intratumoral injection in brain tumor therapies, showcasing his innovative approach to harnessing viral mechanisms for therapeutic applications.
Career Highlights
Throughout his career, Michael Dahm has worked with prestigious research institutions, including the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. His affiliations with these organizations underscore his dedication to the advancement of cancer research and treatment methodologies. Dahm’s substantial contributions to the development of novel therapies reflect his expertise and commitment to the field.
Collaborations
Michael Dahm has collaborated with esteemed colleagues such as Jean Rommelaere and Barbara Leuchs, enhancing the collaborative efforts in cancer research. These partnerships have played a crucial role in the development of new cancer therapies and have contributed to the rich landscape of innovation within the medical research community.
Conclusion
Michael Dahm's innovative patents and collaborative efforts in cancer therapy exemplify the vital role inventors play in medical advancements. His research, particularly in the areas of oncolytic viruses and parvovirus formulations, offers hope for more effective cancer treatments. As he continues to push the boundaries of science, the impact of his work is expected to resonate within the fields of oncology and virology for years to come.